- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.08. | Exousia Bio, Inc. - 15-12G, Securities registration termination | 1 | SEC Filings | ||
| 04.08. | L A M Y: Exousia Bio Nearing Completion of Milestone Multimillion-Dollar Capital Investment | 355 | ACCESS Newswire | Strategic Financing to Accelerate Exosome Pipeline Expansion, International Joint Ventures, and Scale-Up of NexTel Medical (MAJI) ORLANDO, FL / ACCESS Newswire / August 4, 2026 / Exousia Bio, Inc. f/k/a... ► Artikel lesen | |
| 22.07. | Exousia Pro, Inc.: NexTel Medical Corp. Amends Previously Announced Acquisition to Acquire Island 40 Group and Full Subsidiary Platform | 223 | GlobeNewswire (Europe) | Revised transaction expands NexTel's acquisition from JumpstartRx and NuevistraMed to Island 40 Group's broader growth platform, adding health services, pharmaceutical access, lab testing, institutional... ► Artikel lesen | |
| 16.06. | Exousia Bio, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 09.06. | Exousia Pro, Inc.: NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University | 794 | GlobeNewswire (Europe) | Led by Scientific Advisory Board Members Dr. John Bitzer and Dr. Marvin Hausman, the Study Utilizes Advanced Mass Spectrometry to Identify the Precise Bioactive Healing Compounds Within Proprietary... ► Artikel lesen | |
| 02.06. | Exousia Pro, Inc.: NexTel Medical Corp. Executes Definitive Purchase Agreements to Acquire JumpstartRx and NueVistraMed, Expanding Telehealth Footprint and Accelerating Maxasome Commercialization | 303 | GlobeNewswire (Europe) | Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to $MAJI shareholders. ORLANDO, Fla., June 02, 2026... ► Artikel lesen | |
| 11.05. | Exousia Pro, Inc.: NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist | 298 | GlobeNewswire (Europe) | ORLANDO, Fla., May 11, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp (f/k/a Exousia Pro, Inc.) (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery... ► Artikel lesen | |
| EXOUSIA Aktie jetzt für 0€ handeln | |||||
| 14.04. | Exousia Bio, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 07.04. | Exousia Pro, Inc.: NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test | 1 | GlobeNewswire (USA) | ||
| 16.03. | Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value | 555 | GlobeNewswire (Europe) | ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 05.03. | Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions | 182 | GlobeNewswire (Europe) | ORLANDO, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is pleased to announce... ► Artikel lesen | |
| 11.12.25 | Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization | 522 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / December 11, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, is excited to announce... ► Artikel lesen | |
| 05.12.25 | Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome: The First All-Natural, Biologically Active Exosomal Supplement | 486 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 02.12.25 | Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms | 555 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the... ► Artikel lesen | |
| 02.12.25 | Exousia Bio, Inc.: LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. | 414 | GlobeNewswire (Europe) | EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the "Company" or "Exo Bio"), operating as... ► Artikel lesen | |
| 17.11.25 | Exousia Pro, Inc.: Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value | 567 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it... ► Artikel lesen | |
| 04.11.25 | Exousia Pro, Inc.: Exousia Pro Announces Breakthrough In Exosome-Based Delivery | 709 | ACCESS Newswire | Successful loading of CBD material accelerates the path to revenue. ORLANDO, FL / ACCESS Newswire / November 4, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused... ► Artikel lesen | |
| 28.10.25 | Exousia Pro, Inc.: Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA | 535 | ACCESS Newswire | Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage. ORLANDO, FLORIDA / ACCESS Newswire / October 28, 2025 / Exousia Pro, Inc. (formerly Marijuana, Inc.) (OTCPINK:MAJI)... ► Artikel lesen | |
| 29.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes | 576 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan... ► Artikel lesen | |
| 26.09.25 | Exousia Pro, Inc.: Exousia Pro Reports Positive Outcome in Legal Proceeding | 565 | ACCESS Newswire | Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SARTORIUS AG VZ | 247,30 | -0,40 % | EQS-News: SARTORIUS Aktiengesellschaft: Sartorius und NIBRT geben Partnerschaft bekannt: Wegweisendes Trainingszentrum für intensivierte und kontinuierliche Bioprozesse entsteht | EQS-News: SARTORIUS Aktiengesellschaft
/ Schlagwort(e): Kooperation
Sartorius und NIBRT geben Partnerschaft bekannt: Wegweisendes Trainingszentrum für intensivierte und kontinuierliche... ► Artikel lesen | |
| 2G ENERGY | 57,70 | -0,26 % | KI-Geheimtipp: Rechenzentren treiben Auftragsbuch: 350 Millionen Euro für 2G Energy | © Foto: Rupert Oberhäuser - Rupert OberhäuserBerenberg startet die Coverage von 2G Energy mit Kursziel 91 Euro. Der Boom bei Rechenzentren und deren Hunger nach Strom für KI treibt das Auftragsbuch... ► Artikel lesen | |
| LIGHTWAVE LOGIC | 5,100 | 0,00 % | Lightwave Logic, Inc. to Attend the 2026 European Conference on Optical Communication & Global Photonics Economic Forum | ENGLEWOOD, CO / ACCESS Newswire / September 16, 2026 / Lightwave Logic, Inc. (NASDAQ:LWLG) (the "Company"), a technology platform company leveraging its proprietary electro-optic (EO) polymers to enable... ► Artikel lesen | |
| PVA TEPLA | 29,080 | 0,00 % | EQS-PVR: PVA TePla AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: PVA TePla AG
PVA TePla AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| UNUSUAL MACHINES | 23,170 | -0,04 % | Unusual Machines, Inc.: Unusual Machines Invests an Additional $20 Million in XTEND AI Robotics, Bringing Total Investment to $27.5 Million | Reinforces Unusual Machines' Commitment to the Growing U.S. Drone and Robotics Ecosystem ORLANDO, FL / ACCESS Newswire / September 9, 2026 / Unusual Machines, Inc. (NYSE American:UMAC), a leading manufacturer... ► Artikel lesen | |
| RESEARCH FRONTIERS | 0,649 | -0,31 % | Research Frontiers Incorporated: Research Frontiers Welcomes Gauzy's Court-Approved Restructuring and the Restart of SPD-Smart Light Control Film Production | WOODBURY, N.Y., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR), the developer and licensor of patented SPD-SmartGlass technology, welcomed the announcement today by Gauzy... ► Artikel lesen | |
| PFEIFFER VACUUM TECHNOLOGY | 164,00 | -0,36 % | EQS-PVR: Pfeiffer Vacuum Technology AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Pfeiffer Vacuum Technology AG
Pfeiffer Vacuum Technology AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading... ► Artikel lesen | |
| SERVE ROBOTICS | 4,395 | -0,34 % | Wonder Deal, $240M Cash, and 31% Short Interest. A Short Squeeze Could Be Brewing in Serve Robotics Stock. | ||
| EVOLV TECHNOLOGIES | 5,030 | 0,00 % | Evolv Technology reports customer growth, product adoption | ||
| DRONESHIELD | 1,046 | -0,43 % | DroneShield-Aktie: Hält diese wichtige Unterstützung? | Die DroneShield-Aktie hat seit ihrem Rekordhoch bei rund 6,80 AUD etwa -75% an Wert verloren und notiert inzwischen bei 1,66 AUD. Allein am Freitag gab der Kurs um weitere -2,35% nach. Damit erreicht... ► Artikel lesen | |
| GPGI | 11,970 | 0,00 % | GPGI, Inc.: Husky Technologies Appoints Mohammad Kanaan as Chief Financial Officer and Karen Stone as Chief Human Resources Officer | BOLTON, Ontario, May 28, 2026 (GLOBE NEWSWIRE) -- GPGI, Inc. (NYSE: GPGI) today announced the appointments of Mohammad Kanaan as Chief Financial Officer and Karen Stone as Chief Human Resources Officer... ► Artikel lesen | |
| AXON ENTERPRISE | 390,40 | +0,15 % | Full Transcript: Axon Enterprise Q2 2026 Earnings Call | ||
| AIRJOULE TECHNOLOGIES | 4,330 | 0,00 % | AirJoule Technologies Corporation: AirJoule Technologies Acquires BitSink, Adding Profitable AI & HPC Infrastructure Cooling Business | Acquisition complements AirJoule Technologies' water technology with BitSink's well-established cooling solutions to address the critical infrastructure requirements of next-generation modular data... ► Artikel lesen | |
| RCM TECHNOLOGIES | 39,360 | -0,08 % | RCM Technologies, Inc. Announces Second Quarter 2026 Results | PENNSAUKEN, N.J., Aug. 13, 2026 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through... ► Artikel lesen | |
| HUDSON TECHNOLOGIES | 5,155 | 0,00 % | Hudson Technologies signs development deal with Icorium |
Das Unternehmen EXOUSIA ADVANCED MATERIALS INC kann der Branche Sonstige Technologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXOUSIA ADVANCED MATERIALS INC finden Sie auf Wallstreet Online.